Laboratorio Elea Phoenix S.A.
Privately held: no public share price
Assets
(3 total)
3Total Assets
0Approved
2Phase 3 / Filed
1Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | PD-1Monoclonal antibody | Non-Small Cell Lung Cancer | |
RacotumomabNo recent activity | Phase 3 | NeuGcGM3 gangliosideMonoclonal antibody | Non-Small Cell Lung Cancer |
| Phase 2 | cannabinoidSmall molecule | Parkinson's DiseaseDravet SyndromeLennox-Gastaut Syndrome |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.